[go: up one dir, main page]

MX9705937A - Procedimiento de preparacion de genoma de adenovirus recombinantes. - Google Patents

Procedimiento de preparacion de genoma de adenovirus recombinantes.

Info

Publication number
MX9705937A
MX9705937A MX9705937A MX9705937A MX9705937A MX 9705937 A MX9705937 A MX 9705937A MX 9705937 A MX9705937 A MX 9705937A MX 9705937 A MX9705937 A MX 9705937A MX 9705937 A MX9705937 A MX 9705937A
Authority
MX
Mexico
Prior art keywords
preparing
recombinant adenovirus
adenovirus genome
adenoviruses
disclosed
Prior art date
Application number
MX9705937A
Other languages
English (en)
Inventor
Joel Crouzet
Laurent Naudin
Cecile Orsini
Emmanuelle Vigne
Patrice Yeh
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9476085&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9705937(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of MX9705937A publication Critical patent/MX9705937A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invencion se refiere aun nuevo procedimiento de preparacion de adenovirus recombinantes, y la utilizacion de dichos adenovirus en terapia génica. Esta se refiere igualmente a los plásmidos utilizados para la construccion de estos adenovirus.
MX9705937A 1995-02-13 1996-02-09 Procedimiento de preparacion de genoma de adenovirus recombinantes. MX9705937A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9501632A FR2730504B1 (fr) 1995-02-13 1995-02-13 Procede de preparation de genomes d'adenovirus recombinants
PCT/FR1996/000215 WO1996025506A1 (fr) 1995-02-13 1996-02-09 Procede de preparation de genome d'adenovirus recombinants

Publications (1)

Publication Number Publication Date
MX9705937A true MX9705937A (es) 1997-10-31

Family

ID=9476085

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9705937A MX9705937A (es) 1995-02-13 1996-02-09 Procedimiento de preparacion de genoma de adenovirus recombinantes.

Country Status (19)

Country Link
US (1) US6261807B1 (es)
EP (1) EP0809704B1 (es)
JP (1) JP3842818B2 (es)
KR (1) KR100575521B1 (es)
AT (1) ATE405662T1 (es)
AU (1) AU716777B2 (es)
BR (1) BRPI9607583B8 (es)
CA (1) CA2210956C (es)
CZ (1) CZ294338B6 (es)
DE (1) DE69637648D1 (es)
FI (1) FI120046B (es)
FR (1) FR2730504B1 (es)
HU (1) HU222808B1 (es)
IL (1) IL117115A (es)
MX (1) MX9705937A (es)
NO (1) NO327980B1 (es)
SK (1) SK286965B6 (es)
WO (1) WO1996025506A1 (es)
ZA (1) ZA961153B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020136708A1 (en) * 1993-06-24 2002-09-26 Graham Frank L. System for production of helper dependent adenovirus vectors based on use of endonucleases
DE19620687A1 (de) * 1996-05-22 1997-11-27 Centeon Pharma Gmbh Neuer adenoviraler Vektor für den Transfer humaner Gene in vivo
ATE256196T1 (de) 1997-06-09 2003-12-15 Genvec Inc Chimäre vektoren, die die verpackungsregion eines phagengenoms und einen teil des genoms eines eukaryontischen virus enthalten
DE69831417T2 (de) * 1997-09-23 2006-06-22 Genvec, Inc. Duale selektionkassette und sie enthaltende plasmide
CA2340276A1 (en) * 1998-08-28 2000-03-09 Duke University Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences
AU769735B2 (en) * 1999-02-18 2004-02-05 Advec, Inc. A system for production of helper dependent adenovirus vectors based on use of endonucleases
FR2794771B1 (fr) 1999-06-11 2001-08-10 Aventis Pharma Sa Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
FR2799472B1 (fr) * 1999-10-07 2004-07-16 Aventis Pharma Sa Preparation d'adenovirus recombinants et de banques adenovirales
WO2001059071A2 (en) * 2000-02-09 2001-08-16 Genvec, Inc. Methods of preparing and using a viral vector library
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US6573092B1 (en) 2000-10-10 2003-06-03 Genvec, Inc. Method of preparing a eukaryotic viral vector
AUPR518501A0 (en) 2001-05-22 2001-06-14 Unisearch Limited Yin yang-1
WO2003049763A1 (en) 2001-12-12 2003-06-19 Fh Faulding & Co Limited Composition for the preservation of viruses
DE602004027538D1 (de) 2003-12-01 2010-07-15 Life Technologies Corp Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
SI2002003T1 (sl) 2005-05-27 2016-05-31 Ospedale San Raffaele S.R.L. Genski vektor, ki vsebuje mi-RNA
MX2009011851A (es) 2007-05-02 2010-03-04 Merial Ltd Plasmidos de dna que tienen expresion y estabilidad mejoradas.
US20110269119A1 (en) 2009-10-30 2011-11-03 Synthetic Genomics, Inc. Encoding text into nucleic acid sequences
EP3372236A1 (en) * 2013-10-25 2018-09-12 PsiOxus Therapeutics Limited Oncolytic adenoviruses armed with heterologous genes
US10076562B2 (en) 2016-04-19 2018-09-18 The Board Of Regents Of The University Of Texas System Methods for treating plague
EA201990711A1 (ru) 2016-09-20 2019-09-30 Бёрингер Ингельхайм Ветмедика Гмбх Новый ehv сайт инсерции orf70
US10329586B2 (en) 2016-09-20 2019-06-25 Boehringer Ingelheim Vetmedica Gmbh Canine adenovirus vectors
MY199909A (en) 2016-09-20 2023-11-29 Boehringer Ingelheim Vetmedica Gmbh Promoters
EP3515480A1 (en) 2016-09-20 2019-07-31 Boehringer Ingelheim Vetmedica GmbH New swine influenza vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE304604T1 (de) * 1993-06-24 2005-09-15 Frank L Graham Adenovirus vektoren für gentherapie
PL179877B1 (pl) * 1993-07-13 2000-11-30 Rhone Poulenc Rorer Sa Zdefektowany replikacyjnie adenowirus, linia komórkowa do infekowania zdefektowanym adenowirusem oraz srodek farmaceutyczny PL PL PL PL PL PL PL PL PL PL
WO1995003400A1 (en) * 1993-07-23 1995-02-02 Johns Hopkins University School Of Medicine Recombinationally targeted cloning in yeast artificial chromosomes
FR2726285B1 (fr) * 1994-10-28 1996-11-29 Centre Nat Rech Scient Adenovirus depourvus de particules contaminantes viables, preparation et utilisation
ES2240980T3 (es) * 1994-10-28 2005-10-16 The Trustees Of The University Of Pennsylvania Adenovirus mejorado y metodos de utilizacion del mismo.
FR2727689A1 (fr) * 1994-12-01 1996-06-07 Transgene Sa Nouveau procede de preparation d'un vecteur viral

Also Published As

Publication number Publication date
FR2730504B1 (fr) 1997-03-28
CA2210956C (fr) 2010-06-08
SK110097A3 (en) 1998-06-03
WO1996025506A1 (fr) 1996-08-22
EP0809704A1 (fr) 1997-12-03
AU716777B2 (en) 2000-03-09
HU222808B1 (hu) 2003-10-28
JPH11500007A (ja) 1999-01-06
CZ294338B6 (cs) 2004-12-15
IL117115A0 (en) 1996-06-18
HUP9800260A1 (hu) 1998-05-28
BR9607583A (pt) 1998-07-07
ATE405662T1 (de) 2008-09-15
BR9607583B1 (pt) 2009-12-01
EP0809704B1 (fr) 2008-08-20
CZ255497A3 (en) 1997-11-12
AU4723596A (en) 1996-09-04
US6261807B1 (en) 2001-07-17
FI973309L (fi) 1997-08-12
IL117115A (en) 2005-06-19
HUP9800260A3 (en) 2000-12-28
NO973663L (no) 1997-08-08
KR19980702139A (ko) 1998-07-15
CA2210956A1 (fr) 1996-08-22
FR2730504A1 (fr) 1996-08-14
NO327980B1 (no) 2009-11-02
FI973309A0 (fi) 1997-08-12
ZA961153B (en) 1996-08-23
FI120046B (fi) 2009-06-15
KR100575521B1 (ko) 2006-10-24
NO973663D0 (no) 1997-08-08
SK286965B6 (sk) 2009-08-06
JP3842818B2 (ja) 2006-11-08
DE69637648D1 (de) 2008-10-02
BRPI9607583B8 (pt) 2016-11-08

Similar Documents

Publication Publication Date Title
MX9705937A (es) Procedimiento de preparacion de genoma de adenovirus recombinantes.
CA2213343A1 (en) Chimeric adenoviral fiber protein and methods of using same
AU7264694A (en) Defective adenovirus vectors and use thereof in gene therapy
AU5723696A (en) Gene therapy using replication competent targeted adenoviral vectors
EP0721341A4 (en) CLONING AND DESCRIPTION OF FULL MAGE-1 GENE CHARACTERISTICS
ZA949104B (en) Recombinant viruses and their use in gene therapy
FI954966L (fi) Puutteellisia yhdistelmä-DNA-adenoviruksia kasvainten geeniterapiassa
AU8147194A (en) Recombinant adenoviruses for gene therapy in cancers
IL114982A0 (en) Use of a defective recombinant adenovirus in gene therapy
AU6144494A (en) Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases
HUP9902150A3 (en) Recombinant adenoviral vectors for human tumour gene therapy
ZA958128B (en) Viral vectors and use in gene therapy
AU7665396A (en) Recombinant viruses containing mobile genetic elements and methods of use in gene therapy
IL112993A0 (en) Recombinant niruses, their preparation and their use in gene therapy
AU2620595A (en) Recombinant viruses, preparation and use thereof in gene therapy
IL112992A0 (en) Recombinant viruses, their preparation and their use in gene therapy
AU1209797A (en) Novel antigenic proteins of mycoplasmata, genes thereof, and recombinant vector and use of the same
GB9604714D0 (en) Recombinant bovine adenovirus vector system and its application in gene therapy and in the development of recombinant vaccine
SI0889969T1 (sl) Rekombinantni adenovirusni vektorji za gensko terapijo humanih tumorjev
IL112994A0 (en) Recombinant viruses, their preparation and their use in gene therapy
AU2003204575A1 (en) Recombinant adenovirus vaccines